Cary Street Partners Investment Advisory’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-716
Closed -$65.2K 1813
2023
Q3
$65.2K Buy
716
+386
+117% +$39.8K ﹤0.01% 798
2023
Q2
$37.2K Buy
330
+25
+8% +$2.64K ﹤0.01% 892
2023
Q1
$31.9K Sell
305
-50
-14% -$5.22K ﹤0.01% 846
2022
Q4
$39.3K Buy
+355
New +$37.2K ﹤0.01% 807
2020
Q4
Sell
-1,086
Closed -$91K 899
2020
Q3
$91K Buy
+1,086
New +$84.5K 0.02% 398

Other funds holding XYL

Cary Street Partners Investment Advisory's XYL Position: Q4 2023 in Review

Cary Street Partners Investment Advisory sold out of Xylem (XYL) in Q4 2023, closing a stake of 716 shares — an estimated $65.2K sold.

Cary Street Partners Investment Advisory first reported a position in XYL in Q3 2020 and held it in 5 quarters. The position peaked at $91K in Q3 2020. 923 funds tracked by Wall St. Rank hold XYL as of Q4 2023.

  • Cary Street Partners Investment Advisory reported no remaining Xylem position as of Q4 2023 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 716 Xylem shares in Q4 2023, an estimated $65.2K.
  • Cary Street Partners Investment Advisory first reported a position in Xylem in Q3 2020 and held it in 5 quarters.
  • Cary Street Partners Investment Advisory's Xylem position peaked at $91K in Q3 2020.
  • 923 funds tracked by Wall St. Rank held Xylem as of Q4 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2023, filed 5 Feb 2024.